Geno Germano
About Geno Germano
Geno Germano is a seasoned executive in the pharmaceutical and healthcare industries, currently serving on the Board of Directors at Precision BioSciences.
Geno Germano Board of Directors at Precision BioSciences
Geno Germano currently holds a position on the Board of Directors at Precision BioSciences. His role involves providing strategic guidance and expertise to help steer the company's initiatives in the field of gene editing and genomic research. Precision BioSciences aims to develop and commercialize therapies to address significant unmet medical needs, and Germano's extensive background in the pharmaceutical and healthcare industries adds considerable value to the organization's governance and strategic planning.
Geno Germano's Pharmaceutical Industry Background
Geno Germano has a notable background in the pharmaceutical and healthcare industries. His career includes significant leadership roles at global pharmaceutical companies, highlighting his expertise in drug development, strategic business management, and operational excellence. Germano's experience spans various aspects of the pharma industry, from research and development to commercialization and corporate governance.
Geno Germano's Role at Allergan
Geno Germano previously served as the President and Chief Operating Officer at Allergan. In this role, he was responsible for overseeing the company’s global commercial operations. His leadership contributed to the company's growth and operational efficiency, leveraging his industry knowledge and strategic acumen to enhance Allergan's market presence and product portfolio.
Geno Germano’s Tenure at Pfizer
Geno Germano held the position of Group President of Pfizer's Global Innovative Pharma Business. During his tenure, he led the division focused on developing and delivering innovative pharmaceutical products. His responsibilities included managing the portfolio of novel therapeutics, driving growth strategies, and ensuring the successful launch and commercialization of new drugs, reinforcing Pfizer's leadership in the pharmaceutical sector.
Geno Germano’s Education
Geno Germano holds a Bachelor of Science in Industrial Engineering from Rutgers University. Additionally, he earned an MBA from New York University's Stern School of Business. His educational background in engineering provides a strong analytical foundation, while his MBA equips him with advanced business management skills, contributing to his effective leadership in the pharmaceutical industry.